Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 11, Issue 498, Pages eaaw2614
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-06-27
DOI
10.1126/scitranslmed.aaw2614
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor elastography and its association with collagen and the tumor microenvironment.
- (2018) Johannes Riegler et al. CLINICAL CANCER RESEARCH
- Collagen disruption as a marker for basal cell carcinoma in presurgical margin detection
- (2018) Pooyan Rohani et al. LASERS IN SURGERY AND MEDICINE
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- Basic Fibroblast Growth Factor Fused with Tandem Collagen-Binding Domains from Clostridium histolyticum Collagenase ColG Increases Bone Formation
- (2018) Hiroyuki Sekiguchi et al. Biomed Research International
- Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma
- (2018) Mark R. Albertini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid)
- (2017) David A Canton et al. Immunotherapy
- Second harmonic generation for collagen I characterization in rectal cancer patients with and without preoperative radiotherapy
- (2017) Stéphanie Blockhuys et al. JOURNAL OF BIOMEDICAL OPTICS
- Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
- (2017) Byron H. Kwan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events
- (2017) Jun Ishihara et al. Science Translational Medicine
- Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions
- (2016) J. T. Poleszczuk et al. CANCER RESEARCH
- Tumor macrophages are pivotal constructors of tumor collagenous matrix
- (2016) Ran Afik et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The extracellular matrix: Tools and insights for the “omics” era
- (2016) Alexandra Naba et al. MATRIX BIOLOGY
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
- (2016) J. Liu et al. Cancer Discovery
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
- (2015) Riccardo Danielli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
- (2015) Mythili Koneru et al. Journal of Translational Medicine
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- Colorful Protein-Based Fluorescent Probes for Collagen Imaging
- (2014) Stijn J. A. Aper et al. PLoS One
- Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis
- (2014) Jimmy LN Vo et al. OncoImmunology
- Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example
- (2013) Angelo Corti et al. BIODRUGS
- Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures
- (2013) Brandon H. Toyama et al. CELL
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo
- (2013) Gabriel R. Starbeck-Miller et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
- (2013) Melissa G. Lechner et al. JOURNAL OF IMMUNOTHERAPY
- Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site
- (2012) Thomas List et al. mAbs
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
- (2011) Matthew W. Conklin et al. AMERICAN JOURNAL OF PATHOLOGY
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions
- (2011) Katharina Frey et al. EXPERIMENTAL DERMATOLOGY
- Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase
- (2011) John D Miller et al. IMMUNOLOGY AND CELL BIOLOGY
- Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing
- (2011) M. M. Martino et al. Science Translational Medicine
- Lumican, a small leucine-rich proteoglycan
- (2008) Dragana Nikitovic et al. IUBMB LIFE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started